CD3-Specific Antibodies as Promising Tools to Aim at Immune Tolerance in the Clinic
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis Ltd in International Reviews of Immunology
- Vol. 25 (3-4), 215-233
- https://doi.org/10.1080/08830180600743032
Abstract
Currently, therapies applied in transplantation and autoimmunity are essentially based on the use of immunosuppressants. These agents depress all immune responses and expose individuals to the recurrence of the pathogenic immune process once they are withdrawn, thus necessitating a chronic administration leading to the risk of recurrent infections and increased frequency of tumors. At variance, CD3 monoclonal antibodies appear unique in their capacity to induce immunological tolerance that is an antigen-specific unresponsiveness in the absence of chronic immunosuppression. This has been well-established in experimental models, and recent data show successful clinical translation using humanized anti-CD3 antibodies. The aim of this brief review is to discuss the main characteristics of these very promising tools and to present the experimental and clinical results arguing for their unique tolerogenic ability.Keywords
This publication has 70 references indexed in Scilit:
- CD3-specific antibody-induced active tolerance: from bench to bedsideNature Reviews Immunology, 2003
- PRECLINICAL STUDIES OF ALLOGRAFT TOLERANCE IN RHESUS MONKEYSTransplantation, 1997
- A NONDEPLETING ANTI-RAT CD4 MONOCLONAL ANTIBODY THAT SUPPRESSES T HELPER 1-LIKE BUT NOT T HELPER 2-LIKE INTRAGRAFT LYMPHOKINE SECRETION INDUCES LONG-TERM SURVIVAL OF RENAL ALLOGRAFTSTransplantation, 1994
- Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: Evidence for inter-T cell-mediated cytolysisClinical Immunology and Immunopathology, 1991
- INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI-CD4 MONOCLONAL ANTIBODY THERAPYTransplantation, 1990
- Hypothermia and hypoglycemia induced by anti‐CD3 monoclonal antibody in mice: Role of tumor necrosis factorEuropean Journal of Immunology, 1990
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsThe New England Journal of Medicine, 1985
- Antigenic modulation - a major mechanism of antibody actionImmunology Today, 1984
- RENAL ALLOGRAFT TOLERANCE INDUCED WITH ATG AND DONOR BONE MARROW IN OUTBRED RHESUS MONKEYSTransplantation, 1983
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsThe New England Journal of Medicine, 1981